BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17182560)

  • 1. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
    Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
    J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
    Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
    J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.
    Morvan M; Willem C; Gagne K; Kerdudou N; David G; Sébille V; Folléa G; Bignon JD; Retière C
    J Immunol; 2009 Jun; 182(11):6727-35. PubMed ID: 19454667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
    Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
    Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.
    O'Connor GM; Yamada E; Rampersaud A; Thomas R; Carrington M; McVicar DW
    J Immunol; 2011 Sep; 187(5):2162-71. PubMed ID: 21804024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection.
    Pascal V; Yamada E; Martin MP; Alter G; Altfeld M; Metcalf JA; Baseler MW; Adelsberger JW; Carrington M; Anderson SK; McVicar DW
    J Immunol; 2007 Aug; 179(3):1625-33. PubMed ID: 17641029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
    Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
    J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
    Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
    PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
    O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
    J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
    Carr WH; Pando MJ; Parham P
    J Immunol; 2005 Oct; 175(8):5222-9. PubMed ID: 16210627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.
    Gillespie GM; Bashirova A; Dong T; McVicar DW; Rowland-Jones SL; Carrington M
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):451-5. PubMed ID: 17411378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
    Martin MP; Qi Y; Gao X; Yamada E; Martin JN; Pereyra F; Colombo S; Brown EE; Shupert WL; Phair J; Goedert JJ; Buchbinder S; Kirk GD; Telenti A; Connors M; O'Brien SJ; Walker BD; Parham P; Deeks SG; McVicar DW; Carrington M
    Nat Genet; 2007 Jun; 39(6):733-40. PubMed ID: 17496894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.
    Boudreau JE; Mulrooney TJ; Le Luduec JB; Barker E; Hsu KC
    J Immunol; 2016 Apr; 196(8):3398-410. PubMed ID: 26962229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.
    Erer B; Takeuchi M; Ustek D; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Duymaz-Tozkir J; Gül A; Kastner DL; Remmers EF; Ombrello MJ
    Genes Immun; 2016 Dec; 17(7):396-399. PubMed ID: 27708262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.